Side effects of 1% cyclopentolate hydrochloride in children and adolescents attended at Centro Universitário FMABC
Main Article Content
Abstract
Introduction: It is known that vision disorders are within the context of public health problems. In childhood, during the neuropsychomotor development phase, visual changes are crucial, since there is a strong correlation between poor school performance and changes in acuity. For these reasons, ophthalmological examination in children, including refraction, is extremely important, aiming at the early diagnosis of diseases and possible refractive errors that may compromise the child's life and development. 1% cyclopentolate hydrochloride eye drops are the most used during ophthalmic clinical evaluation as a cycloplegic and mydriatic agent to assist in refractive examination. Objective: The ocular and systemic side effects of 1% cyclopentolate hydrochloride eye drops were studied in patients who underwent static refractive examination in the strabismus sector of the Ophthalmology Discipline of the Centro Universitário FMABC. Methods: A drop of 1% cyclopentolate is instilled in both eyes of each patient and the possible ocular and systemic signs and symptoms presented were observed after 40 minutes and 24 hours after instillation. Results: we expect to find ocular side effects more evident than systemic symptoms in the two evaluation times (40 minutes and 24 hours after instillation). All symptoms (ocular and systemic) are reversed spontaneously. Conclusion: The present study aims to show that the side effects observed by the topical (ocular) use of cyclopentolate eye drops 1% are few and present spontaneous reversal both from an eye point of view, as well as from a systemic point of view.
Downloads
Article Details
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY) that allows others to share and adapt the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.References
2. Granzoto JA, Ostermann CSPE, Brum LF, Pereira PG, Granzoto T. Avaliação da acuidade visual em escolares da 1ª série do ensino fundamental. Arq Bras Oftalmol. 2003;66(2):167-71. https://doi.org/10.1590/S0004-27492003000200010
3. Gianini RJ Masi E, Coelho EC, Oréfice FR, Moraes RA. Prevalência de baixa acuidade visual em escolares da rede pública, Sorocaba. Rev Saúde Pública. 2004;38(2):201-8. https://doi.org/10.1590/S0034-89102004000200008
4. Ocak OB, Inal A, Aygün BT, Kabakci AK, Atik BK, Ocak SY, et al. Refraction under general anesthesia in children, using cycloplegic refraction only as a reference. Strabismus. 2020;28(2):73-8. https://doi.org/10.1080/09273972.2020.1714669
5. Egashira SM, Kish LL, Twelker JD, Mutti DO, Zadnik K, Adams AJ. Comparison of cyclopentolate versus tropicamide cycloplegia in children. Optom Vis Sci. 1993;70(12):1019-26. https://doi.org/10.1097/00006324-199312000-00005
6. Bhatia SS, Vidyashankar C, Sharma RK, Dubey AK. Systematic ticity whith cyclopentolate eye drops. Indian Pediatr. 2000;37(3):329-31.
7. Reynolds JEF. Martindale, the Extra Pharmacopoeia. J Pharm Pharmacol. 1990;42:888.
8. Brasil. Ministério da Saúde. Secretaria de Ciência, Tecnologia e Insumos Estratégicos Departamento de Assistência Farmacêutica e Insumos Estratégicos. Formulário Terapêutico Nacional 2010: Rename 2010. Brasília: Ministério da Saúde, 2010.
9. Binkhosrst RD, Weinstein GW, Baretz C, Clahane AC. Psychotic reation induced by cyclopentolate (Cyclogyl). Results of pilot study and a double-blind study. Am J Ophthalmol. 1963;55:1243-5.
10. Gordon DM, Ehrenberg MH. Cyclopentolate hydrochloride: a new mydriatic and cyclopegic agent; a pharmacologic and clinical evaluation. Am J Ophthalmol. 1954;38(6):831-8. https://doi.org/10.1016/0002-9394(54)90413-4
11. Stolzar IH. A new group of cyclopegic drugs. Am J Ophthalmol. 1953;36(1):110-2. https://doi.org/10.1016/0002-9394(53)91517-7
12. Newman DK, Jordan K. Generalised urticarial induced by topical cyclopentolate. Eye. 1996;10 (Pt6):750-1. https://doi.org/10.1038/eye.1996.176
13. Mirshahi A, Kohnen T. Acute psychotic reaction caused by topical cyclopentolate use for cyclopegic refration before refractive surgery: case report and review of the literature. J Cataract Refract Surg. 2003;29(5):1026-30. https://doi.org/10.1016/s0886-3350(02)01651-6
14. Jones LW, Hodes DT. Possible allergic reactions to cyclopentolate hydrochloride: case report with literature rewiew of uses and adverse reactions. Ophthalmic Physiol Opt. 1991;11(1):16-21.
15. Hermansen MC, Sullivan LS. Feeding intolerance following ophthalmologic examination. Am JDis Child. 1985;139(4):367-8. https://doi.org/10.1001/archpedi.1985.02140060049026